Hepatitis viruses and liver transplantation

Journal of Gastroenterology and Hepatology (Australia)

Volumn 12, Issue 9-10, 1997, Pages

  Samuel, Didier ^a   Feray, Cyrille ^a   Bismuth, Henri ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Antiviral treatment; Hepatitis B virus; Hepatitis C virus; Liver transplantation

Indexed keywords

FAMCICLOVIR; GANCICLOVIR; INTERFERON; RIBAVIRIN; VIDARABINE PHOSPHATE;

CONFERENCE PAPER; GENOTYPE; GRAFT SURVIVAL; HEPATITIS VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPROPHYLAXIS; INFECTION RISK; LIVER TRANSPLANTATION; PREVALENCE; PRIORITY JOURNAL; RECURRENCE RISK; REINFECTION; VIRUS REPLICATION;

EID: 0030785213     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1997.tb00518.x     Document Type: Conference Paper

References (44)

1. Demetris AJ, Jaffe R, Sheahan DG et al. Recurrent hepatitis B in liver allograft recipients. Differentiation between viral hepatitis B and rejection. Am. J. Pathol. 1986; 125: 161-72.
2. Demetris AJ, Todo S, van Thiel DH et al. Evolution of hepatitis B virus liver disease after hepatic replacement. Practical and theoretical considerations. Am. J. Pathol. 1990; 137: 667-76.
3. Todo S, Demetris AJ, van Thiel D, Teperman L, Fung J, Starzl TE. Orthotopic liver transplantation for patients with hepatitis B virus related liver disease. Hepatology 1991; 13: 619-26.
4. O'Grady JG, Smith HM, Davies SE et al. Hepatitis B reinfection after orthotopic liver transplantation. Serological and clinical implications. J. Hepatol. 1992; 14: 104-11.
5. Feray C, Zignego AL, Samuel D et al. Persistent hepatitis B virus infection of mononuclear cells without concomitant liver infection: The liver transplantation model. Transplantation 1990; 49: 1155-8.
6. Trautwein C, Shrem H, Tillmann HL et al. Hepatitis virus mutations in the pre-S genome before and after liver transplantation. Hepatology 1996; 24: 482-8.
7. Brind A, Jiang JJ, Samuel D et al. Evidence for the role of PBMC in the infection of liver graft and selection of hepatitis B variants after liver transplantation. J. Hepatol. 1996; 26: 228-35.
8. Samuel D, Bismuth A, Mathieu D et al. Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients. Lancet 1991; 337: 813-15.
9. Samuel D, Muller R, Alexander G et al. Liver transplantation in European patients with the hepatitis B surface antigen. N. Engl. J. Med. 1993; 329: 1842-7.
10. Muller R, Gubernatis G, Farle M et al. Liver transplantation in HBs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunisation. J. Hepatol. 1991; 13: 90-6.
11. Phillips MJ, Cameron R, Flowers MA et al. Post-transplant recurrent hepatitis B viral liver disease. Viral-burden, steato-viral, and fibroviral hepatitis. Am. J. Pathol. 1992; 140: 1295 308.
12. Davies SE, Portmann BC, O'Grady JG et al. Hepatic histologie findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis. Hepatology 1991; 13: 150-7.
13. Lau JYN, Bain VG, Davies SE et al. High-level expression of hepatitis B viral antigens in fibrosing cholestatic hepatitis. Gastroenterology 1992; 102: 956-62.
14. Lauchart W, Müller R, Pichlmayr R. Long-term immunoprophylaxis of hepatitis B virus: HBV reinfection in recipients of human liver allografts. Transplant. Proc. 1987; 19: 4051-3.
15. Muller R, Samuel D, Fassati L et al. 'EUROHEP' consensus report on the management of liver transplantation for hepatitis B virus infection. J. Hepatol. 1994; 21: 1140-3.
16. Jury of the International Consensus Conference on Indications of Liver Transplantation. Consensus statement on indications for liver transplantation: Paris, June 22-3, 1993. Hepatology 1994; 20: S63-8.
17. Marcellin P, Samuel D, Areias J, Gigou M, Benhamou JP, Bismuth H. Pretransplant interferon treatment and recurrence of hepatitis B virus infection after liver transplantation for hepatitis B-related end-stage liver disease. Hepatology 1994; 19: 6-12.
18. Grellier L, Mutimer D, Ahmed M et al. Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet 1996; 348: 1212-15.
19. Wright HI, Gavaler JS, van Thiel DH. Preliminary experience with alpha 2b interferon therapy of viral hepatitis in liver allograft recipients. Transplantation 1992; 53: 121-4.
20. Terrault NA, Combs Holland C, Ferrel L et al. Interferon alfa for recurrent hepatitis B infection after liver transplantation. Liver Transplant. Surg. 1996; 2: 132-8.
21. Marcellin P, Samuel D, Loriot MA, Areias J, Bismuth H, Benhamou JP. Anti-viral effect of adenine arabinoside monophosphate (ARA-AMP) in patients with recurrence of hepatitis B virus (HBV) infection after liver transplantation. Hepatology 1990; 12: 966 (Abstract).
22. Gish RG, Lau JYN, Brooks L et al. Ganciclovir treatment of hepatitis B virus (HBV) infection in liver transplant patients. Hepatology 1996; 23: 1-7.
23. Kruger M, Tillmann HL, Trautwein C et al. Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: A pilot study. Liver Transplant. Surg. 1996; 2: 253-62.
24. Ottobrelli A, Marzano A, Smedile A et al. Patterns of hepatitis delta virus reinfection and disease in liver transplantation. Gastroenterology 1991; 101: 1649-55.
25. Samuel D, Zignego AL, Reynes M et al. Long-term clinical and virologic outcome after liver transplantation for cirrhosis due to chronic delta hepatitis. Hepatology 1995; 21: 333-9.
26. Krogsgaard K, Kryger P, Aldershvile J et al. Delta infection and suppression of hepatitis B virus replication in chronic HBsAg carriers. Hepatology 1987; 7: 42-5.
27. Rizzetto M, Chiaberge E, Negro F et al. Liver transplantation in hepatitis delta virus disease. Lancet 1987; ii: 469-71.
28. Martin P, Munoz SJ, di Bisceglie AM et al. Recurrence of hepatitis C virus infection after orthotopic liver transplantation. Hepatology 1991; 13: 719-21.
29. Read AE, Donegan E, Lake J et al. Hepatitis C in patients undergoing liver transplantation. Ann. Intern. Med. 1991; 114: 282-4.
30. Poterucha, Rakel J, Lumeng L, Lee CH, Taswell HF, Wiesner RH. Diagnosis of chronic hepatitis C after liver transplantation by the detection of viral sequences with polymerase chain reaction. Hepatology 1992; 15: 42 5.
31. Wright TL, Donegan E, Hsu H et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 1992; 103: 317-22.
32. Feray C, Samuel D, Thiers V et al. Reinfection of liver graft by hepatitis C virus after liver transplantation. J. Clin. Invest. 1992; 89: 1361-5.
33. König V, Bauditz J, Lobeck H et al. Hepatitis C virus reinfection in allografts after orthotopic liver transplantation. Hepatology 1992; 16: 1137-43.
34. Feray C, Gigou M, Samuel D et al. The course of hepatitis C virus infection after liver transplantation. Hepatology 1994; 20: 1137-43.
35. Gane E, Portmann BC, Naoumov NV et al. Long-term outcome of hepatitis C virus infection after liver transplantation. N. Engl. J. Med. 1996; 334: 815-20.
36. Chazouilleres O, Kim M, Ferrel L et al. Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology 1994; 106: 994-9.
37. Gane E, Naoumov NV, Quian KP et al. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology 1996; 110: 167-77.
38. di Martino V, Feray C, Saurini F, Samuel D, Reynes M, Bismuth H. Relation between intrahepatic replication, genotypes and recurrent liver diseases due to hepatitis C virus after liver transplantation. J. Hepatol. 1996; 25 (Suppl. 1): 152 (Abstract).
39. Feray C, Gigou M, Samuel D et al. Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology 1995; 108: 1089-97.
40. Wright TL, Combs C, Kim M et al. Interferon-alpha therapy for hepatitis C virus infection after liver transplantation. Hepatology 1994; 20: 773-9.
41. Feray C, Samuel D, Gigou M, Reynes M, Bismuth H. An open trial of interferon alpha recombinant for hepatitis C after liver transplantation: Antiviral effects and risk of rejection. Hepatology 1995; 22: 1084-9.
42. Dousset B, Conti F, Houssin D, Calmus Y. Acute vanishing bile duct syndrome after interferon therapy for recurrent HCV infection in liver transplant recipients. N. Engl. J. Med. 1995; 330: 1160-1 (Letter).
43. Gane E, Tibbs CJ, Ramage JK, Portmann BC, Williams R. Ribavirin therapy for hepatitis C infection following liver transplantation. Transplant. Int. 1995; 8: 61-4.
44. Bizollon T, Ducerf C, Trepo C. New approaches to the treatment of hepatitis C virus infection after liver transplantation using ribavirin. J. Hepatol. 1995; 23 (Suppl. 2): 22-5.